Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00422487
Status:
COMPLETED
Last Update Posted:
2015-05-01
First Post:
2007-01-15
Brief Title:
Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes
Sponsor:
CymaBay Therapeutics Inc
Organization:
CymaBay Therapeutics Inc
Organization Data
Organization:
CymaBay Therapeutics Inc
Class:
INDUSTRY
Study ID:
M2044-20610
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CymaBay Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None